Global burden of disease in young people aged 10–24 years: a systematic analysis

Gore, Fiona; Bloem, Paul; Patton, George C.; Ferguson, Jane; Joseph, Veronique; Coffey, Carolyn; Sawyer, Susan Μ; Mathers, Colin

doi:10.1016/s0140-6736(11)60512-6

Cited by 1,798 publications

(1,354 citation statements)

References 15 publications

Supporting

Mentioning

1,273

Contrasting

Unclassified

Order By: Relevance

“…The impact that BD has on young people is even greater, with being the sixth leading cause of disability‐adjusted life years among people aged 10‐24 years worldwide 25. The burden of this disease was further emphasized in a systematic review addressing cost of illness studies, with findings demonstrating that the worldwide annual costs per person with BD range from US $1904 to $33 090; higher per person costs associated with BDI, delayed or misdiagnosis, frequent psychiatric interventions, use of atypical antipsychotics, treatment non‐adherence, poor prognosis, relapse, and comorbidity 26…”

Section: Foundations Of Managementmentioning

confidence: 99%

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

et al. 2018

View full text Add to dashboard Cite

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were published in collaboration with the International Society for Bipolar Disorders (ISBD). These 2018 CANMAT and ISBD Bipolar Treatment Guidelines represent the significant advances in the field since the last full edition was published in 2005, including updates to diagnosis and management as well as new research into pharmacological and psychological treatments. These advances have been translated into clear and easy to use recommendations for first, second, and third‐ line treatments, with consideration given to levels of evidence for efficacy, clinical support based on experience, and consensus ratings of safety, tolerability, and treatment‐emergent switch risk. New to these guidelines, hierarchical rankings were created for first and second‐ line treatments recommended for acute mania, acute depression, and maintenance treatment in bipolar I disorder. Created by considering the impact of each treatment across all phases of illness, this hierarchy will further assist clinicians in making evidence‐based treatment decisions. Lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazine alone or in combination are recommended as first‐line treatments for acute mania. First‐line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, lurasidone, or adjunctive lamotrigine. While medications that have been shown to be effective for the acute phase should generally be continued for the maintenance phase in bipolar I disorder, there are some exceptions (such as with antidepressants); and available data suggest that lithium, quetiapine, divalproex, lamotrigine, asenapine, and aripiprazole monotherapy or combination treatments should be considered first‐line for those initiating or switching treatment during the maintenance phase. In addition to addressing issues in bipolar I disorder, these guidelines also provide an overview of, and recommendations for, clinical management of bipolar II disorder, as well as advice on specific populations, such as women at various stages of the reproductive cycle, children and adolescents, and older adults. There are also discussions on the impact of specific psychiatric and medical comorbidities such as substance use, anxiety, and metabolic disorders. Finally, an overview of issues related to safety and monitoring is provided. The CANMAT and ISBD groups hope that these guidelines become a valuable tool for practitioners across the globe.

show abstract

Section: Foundations Of Managementmentioning

confidence: 99%

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

et al. 2018

View full text Add to dashboard Cite

show abstract

“…[54][55][56] Whilst usually initiated during adolescence, the frequency of engagement in such behaviours increases during teenage years into early adulthood. 57,58 There is an association between early alcohol use and multiple risk behaviours.…”

Section: Behaviourmentioning

confidence: 99%

Understanding why children die in high-income countries

et al. 2014

View full text Add to dashboard Cite

Copyright and reuse:The Warwick Research Archive Portal (WRAP) makes this work of researchers of the University of Warwick available open access under the following conditions. Copyright © and all moral rights to the version of the paper presented here belong to the individual author(s) and/or other copyright owners. To the extent reasonable and practicable the material made available in WRAP has been checked for eligibility before being made available.Copies of full items can be used for personal research or study, educational, or not-forprofit purposes without prior permission or charge. Provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. AbstractThrough a structured narrative review of the literature, we have identified a wide range of factors influencing child and adolescent mortality in high income countries. These can be conceptualised within the four domains of intrinsic factors, the physical environment, the social environment, and service delivery factors. The most prominent factors in the literature are socio-economic gradients, although the mechanisms through which these gradients exert their effects are complex, affecting all four domains, and often poorly understood. While some factors are relatively fixed, including the child's gender, age, ethnicity and inherent genetic make-up, some parental characteristics, and some wider 3 environmental conditions, others may be amenable to interventions that could lessen risks and help to prevent future child deaths. A number of examples of systemic health service factors that may impact child survival are given, along with interventions such as modifications to the physical or social environmental that may impact more distal factors.

show abstract

“…Furthermore, neuropsychiatric disorders are the most common causes of burden and disability in young persons aged 10-24 years in whom they account for 45 % of these, and are strongly associated with risk-behaviors and substantial psychosocial impairment [2][3][4][5]. An important concern is the duration of untreated illness which has been increasingly considered as a predictor of worse outcome across different psychiatric disorders [6].…”

Section: Introductionmentioning

confidence: 99%

Screening instruments in child and adolescent psychiatry: general and methodological considerations

Michel

Schultze‐Lutter

Schimmelmann

2014

Eur Child Adolesc Psychiatry

View full text Add to dashboard Cite

Global burden of disease in young people aged 10–24 years: a systematic analysis

Cited by 1,798 publications

References 15 publications

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

Understanding why children die in high-income countries

Screening instruments in child and adolescent psychiatry: general and methodological considerations

Contact Info

Product

Resources

About